CERT
Certara, Inc. · NASDAQ
- Sector Technology Services
- Industry Packaged Software
- Website certara.com
- Employees(FY) 1150
- ISIN US15687V1098
Performance
-4.44%
1W
-9.92%
1M
-1.03%
3M
+29.97%
6M
-7.05%
YTD
-30.19%
1Y
Profile
Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Australia, Canada, China, France, Germany, India, Italy, Japan, Luxembourg, the Netherlands, the Philippines, Poland, Portugal, Spain, Switzerland, and the United Kingdom. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
Investment Analysis Report: CERT
Overview
In this investment analysis report, we will delve into the financial statements of CERT, a company operating in the Technology Services sector within the Packaged Software industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating cas...
Technical Analysis of CERT 2024-05-03
Overview:
In analyzing the technical indicators for the stock based on the last 5 days of data, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions to ...
Recent News & Updates
- 2024-05-08 05:48
Certara Q1 Adjusted Earnings Down, Revenue Increases(MT Newswires)
- 2024-05-08 04:13
- 2024-05-07 18:40
- 2024-05-07 17:59
- 2024-05-07 16:15
Certara Reports First Quarter 2024 Financial Results(GlobeNewswire)
- 2024-05-07 04:15
Certara Reports First Quarter 2024 Financial Results(Globenewswire)
- 2024-05-06 03:19
What Makes Certara (CERT) an Attractive Bet?(Insider Monkey)
- 2024-05-05 15:19
What Makes Certara (CERT) an Attractive Bet?(Insidermonkey)
- 2024-04-16 08:00
- 2024-04-15 20:00
- 2024-04-09 16:15
- 2024-04-09 04:15
- 2024-04-04 19:01
- 2024-04-01 08:00
- 2024-03-22 09:25
- 2024-03-03 09:45
Certara Full Year 2023 Earnings: EPS Misses Expectations(Simply Wall St.)
- 2024-03-02 08:41
Certara, Inc. (NASDAQ:CERT) Q4 2023 Earnings Call Transcript(Insider Monkey)
- 2024-03-01 19:41
Certara, Inc. (NASDAQ:CERT) Q4 2023 Earnings Call Transcript(Insidermonkey)
- 2024-03-01 07:10
Q4 2023 Certara Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-02-29 18:05
- 2024-02-29 16:52
- 2024-02-29 16:10
Certara Reports Fourth Quarter 2023 Financial Results(GlobeNewswire)
- 2024-02-29 03:10
Certara Reports Fourth Quarter 2023 Financial Results(Globenewswire)
- 2024-02-21 06:42
Is It Time To Consider Buying Certara, Inc. (NASDAQ:CERT)?(Simply Wall St.)
- 2024-02-01 16:30
- 2024-02-01 03:30
- 2024-01-31 23:03
Baillie Gifford Adjusts Position in Certara Inc(GuruFocus.com)
- 2024-01-09 07:58
Returns On Capital At Certara (NASDAQ:CERT) Have Stalled(Simply Wall St.)
- 2023-12-13 16:30
- 2023-12-13 03:30
Page 1 of 5
previousnext